Klippel-Trenaunay综合征患者浅静脉与深静脉病变的治疗选择
单中心回顾性综述34例Klippel-Trenaunay综合征(KTS)患者,2000年1月至2020年12月期间在保守治疗失败后接受静脉干预(含髂股静脉支架)。结果显示浅静脉和深静脉干预安全有效,静脉临床严重度评分和疼痛评分均改善,髂股静脉支架可作为慢性深静脉梗阻的新选择。
要点
- KTS患者保守治疗失败后,浅静脉和深静脉干预安全有效。
- 髂股静脉支架是KTS慢性深静脉梗阻可考虑的新选择。
- 应实施积极的围术期深静脉血栓预防方案以减少血栓栓塞并发症。
核心结论
- 保守治疗失败后,浅静脉和深静脉干预对KTS患者安全有效。
- 髂股静脉支架是KTS慢性深静脉梗阻在适当临床背景下应考虑的新选择。
- 应实施积极的围术期深静脉血栓预防方案以减少血栓栓塞并发症。
研究设计与样本
- 单中心回顾性数据综述,纳入2000年1月至2020年12月期间因静脉疾病接受干预的34例KTS患者。
主要发现
- 患者平均年龄38.4±17.5岁(范围12-80岁),无性别倾向。
- 34例中61%具备KTS经典三联征全部三个特征;所有34例(100%)存在静脉曲张,30%有曲张静脉出血史;79%为CEAP≥C4级。
- 34例中30%有深静脉血栓和/或肺栓塞史;凝血因子VIII升高是最常见的易栓症(12%)。
- 静脉充盈指数基线为5.9±5.1 mL/s,干预后为3.5±2.3 mL/s(P = .04),未恢复正常。
- 静脉临床严重度评分从9.4±4.5改善至6.2±5.6(P = .04);疼痛视觉模拟评分从5.5±2.7改善至2.5±3.3(P = .008);75%的患者溃疡愈合。
关键数值与推荐
- 浅静脉干预(n=35)包括腔内激光治疗、大隐静脉/小隐静脉/股前静脉/边缘静脉剥脱、超声引导硬化治疗和曲张静脉点式剥脱;另行1例穿通静脉弹簧圈栓塞。
- 深静脉干预(n=19)包括腔内支架(n=15)、腘静脉松解(n=3)和瓣膜成形术(n=1)。
- 20项慢性静脉疾病生活质量问卷中,总疼痛域(P = .04)和总心理域(P = .03)显著改善。
临床怎么用
- 保守治疗失败后,可对KTS患者行浅静脉和深静脉干预。
- 髂股静脉支架可在适当临床背景下考虑用于KTS慢性深静脉梗阻。
- 应实施积极的围术期深静脉血栓预防方案。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Klippel-Trenaunay syndrome (KTS) is a congenital mixed mesenchymal malformation syndrome that includes varicose veins, capillary and venous malformations, lymphatic abnormalities, and hypertrophy of various connective tissue elements. The purpose of the present study was to describe the clinical characteristics and outcomes in a subset of patients with KTS in whom venous interventions, including iliofemoral venous stenting, were performed after failure of conservative therapy. METHODS: A single-center retrospective data review of 34 patients with KTS who had undergone interventions for venous disease between January 2000 and December 2020 was performed. RESULTS: Their mean age was 38.4 ± 17.5 years (range, 12-80 years). No gender predilection was found. Of the 34 patients, 61% had had all three features of the classic triad for KTS. Varicose veins were present in all 34 patients (100%), and 30% had had a history of bleeding varicosities. Most patients (79%) had CEAP (Clinical, Etiology, Anatomy, and Pathophysiology) class ≥C4. Of the 34 patients, 30% had a history of deep vein thrombosis and/or pulmonary embolism. Factor VIII elevation was the most common thrombophilia condition (12%). The venous filling index was elevated at baseline (5.9 ± 5.1 mL/s) and did not normalize despite intervention (3.5 ± 2.3 mL/s; P = .04). The superficial venous interventions (n = 35) included endovenous laser therapy; stripping of the great saphenous vein, small saphenous vein, anterior thigh vein, or marginal vein; ultrasound-guided sclerotherapy; and stab avulsion of varicose veins. One coil embolization of a perforator vein was performed. Deep interventions (n = 19) included endovenous stenting (n = 15), popliteal vein release (n = 3), and valvuloplasty (n = 1). The venous clinical severity score had improved from 9.4 ± 4.5 to 6.2 ± 5.6 (P = .04). The visual analog scale for pain score had improved from 5.5 ± 2.7 to 2.5 ± 3.3 (P = .008). Healing of ulceration was noted in 75% of the patients. Significant improvements in the total pain (P = .04) and total psychological (P = .03) domains were noted in the 20-item chronic venous disease quality of life questionnaire. CONCLUSIONS: Superficial and deep venous interventions are safe and effective in patients with KTS when conservative therapy has failed. Iliofemoral venous stenting is a newer option that should be considered in the treatment of chronic deep venous obstructive disease in patients with KTS in the appropriate clinical context. An aggressive perioperative deep vein thrombosis prophylaxis protocol should be in place to reduce thromboembolic complications in these patients.
引用
- Saleem T, Luke C, Raju S, et al. Options in the treatment of superficial and deep venous disease in patients with Klippel-Trenaunay syndrome. J Vasc Surg Venous Lymphat Disord. 2022. PMID: 35779829. doi:10.1016/j.jvsv.2022.04.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。